Machine-Learning Prediction and Reducing Overdoses with EHR Nudges

Description

The goal of this cluster randomized clinical trial is to test a clinician-targeted behavioral nudge intervention in the Electronic Health Record (EHR) for patients who are identified by a machine-learning based risk prediction model as having an elevated risk for an opioid overdose. The clinical trial will evaluate the effectiveness of providing a flag in the EHR to identify individuals at elevated risk with and without behavioral nudges/best practice alerts (BPAs) as compared to usual care by primary care clinicians. The primary goals of the study are to improve opioid prescribing safety and reduce overdose risk.

Conditions

Opioid Overdose, Opioid Use, Opioid Use Disorder, Opioids

Study Overview

Study Details

Study overview

The goal of this cluster randomized clinical trial is to test a clinician-targeted behavioral nudge intervention in the Electronic Health Record (EHR) for patients who are identified by a machine-learning based risk prediction model as having an elevated risk for an opioid overdose. The clinical trial will evaluate the effectiveness of providing a flag in the EHR to identify individuals at elevated risk with and without behavioral nudges/best practice alerts (BPAs) as compared to usual care by primary care clinicians. The primary goals of the study are to improve opioid prescribing safety and reduce overdose risk.

Machine-Learning Prediction and Reducing Overdoses with EHR Nudges

Machine-Learning Prediction and Reducing Overdoses with EHR Nudges

Condition
Opioid Overdose
Intervention / Treatment

-

Contacts and Locations

Pittsburgh

University of Pittsburgh, Pittsburgh, Pennsylvania, United States, 15213

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Received an opioid prescription within the past year
  • * Age 18 years or older at the time of the opioid prescription
  • * At least one visit to an internal medicine or family care practice within the past year
  • * Diagnosis of malignant cancer within the past year
  • * Enrollment in hospice care

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of Pittsburgh,

Walid F Gellad, MD, MPH, PRINCIPAL_INVESTIGATOR, University of Pittsburgh Center for Pharmaceutical Policy and Prescribing

Study Record Dates

2026-03